Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 5Completed 5Unknown 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 5Polycystic Ovary Syndrome 4Pancreatic Neoplasms 2Neoplasm Metastasis 2Insulin Resistance 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Myeloid 1Racism 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Infertility 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectum 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Brain Neoplasms 1Anovulation 1

Interventions

Oxaliplatin 20Fluorouracil 20Leucovorin 19Bevacizumab 16Cetuximab 13Irinotecan 12Capecitabine 8regorafenib 5Radiotherapy 5Nivolumab 5Drug Therapy 5aflibercept 4Radiosurgery 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4Chemotherapy, Adjuvant 4Biopsy 4pembrolizumab 3durvalumab 3atezolizumab 3Specimen Handling 3Folfox protocol 3Cyclophosphamide 3trifluridine tipiracil drug combination 2tremelimumab 2tislelizumab 2poly(I).poly(c12,U) 2futuximab 2fludarabine 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Colorectal Neoplasms × Metformin × Clear all
NCT05158374 2025-02-06

Molecular Effects of Aspirin & Metformin on Colonic Epithelium

University of Edinburgh

Phase NA Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡